December is a peak month for the spread of respiratory syncytial virus, or RSV, a respiratory virus that causes mild cold-like symptoms and poses a special risk for babies and older adults.

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

Nearly 1,000 flu cases have been reported to the Erie County Department of Health since Oct. 1 but only seven RSV cases have ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Morning! Today, we preview a contentious generic drug dispute that may end up at the Supreme Court, discuss how the FDA’s new stance on vaccines could impact RSV shots, and more.

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. When Laura Ehrlich gave birth to her ...